|
CN105392790B
(zh)
|
2013-08-19 |
2019-04-19 |
豪夫迈·罗氏有限公司 |
4H-吡啶并[1,2-a]嘧啶-4-酮化合物制备用于预防或治疗癌症的药物的用途
|
|
GB201410693D0
(en)
|
2014-06-16 |
2014-07-30 |
Univ Southampton |
Splicing modulation
|
|
AU2015327836B2
(en)
|
2014-10-03 |
2021-07-01 |
Cold Spring Harbor Laboratory |
Targeted augmentation of nuclear gene output
|
|
EP4249472A3
(en)
|
2015-05-30 |
2023-12-13 |
PTC Therapeutics, Inc. |
Methods for modulating rna splicing
|
|
CN108603230A
(zh)
|
2015-10-09 |
2018-09-28 |
南安普敦大学 |
基因表达的调节与蛋白质表达失调的筛选
|
|
CN110946865B
(zh)
*
|
2015-12-10 |
2024-01-26 |
Ptc医疗公司 |
用于治疗亨廷顿病的方法
|
|
US11096956B2
(en)
|
2015-12-14 |
2021-08-24 |
Stoke Therapeutics, Inc. |
Antisense oligomers and uses thereof
|
|
EP3390636B1
(en)
|
2015-12-14 |
2021-05-19 |
Cold Spring Harbor Laboratory |
Antisense oligomers for treatment of dravet syndrome
|
|
WO2018098446A1
(en)
|
2016-11-28 |
2018-05-31 |
Ptc Therapeutics, Inc |
Methods for modulating rna splicing
|
|
EP3634953B1
(en)
|
2017-06-05 |
2024-01-03 |
PTC Therapeutics, Inc. |
Compounds for treating huntington's disease
|
|
BR112019026508A2
(pt)
|
2017-06-14 |
2020-07-14 |
Ptc Therapeutics, Inc. |
métodos para modificar o splicing do rna
|
|
CN111163838B
(zh)
|
2017-06-28 |
2023-03-28 |
Ptc医疗公司 |
用于治疗亨廷顿氏病的方法
|
|
MX2019015578A
(es)
|
2017-06-28 |
2020-07-28 |
Ptc Therapeutics Inc |
Metodos para tratar la enfermedad de huntington.
|
|
RU2020105929A
(ru)
*
|
2017-08-04 |
2021-09-06 |
Скайхоук Терапьютикс, Инк. |
Способы и композиции для модулирования сплайсинга
|
|
EP3673080B1
(en)
|
2017-08-25 |
2023-10-18 |
Stoke Therapeutics, Inc. |
Antisense oligomers for treatment of conditions and diseases
|
|
RS66633B1
(sr)
|
2017-10-23 |
2025-08-29 |
Stoke Therapeutics Inc |
Antisens oligomeri za lečenje bolesti i stanja na bazi besmisleno posredovanog raspadanja rnk
|
|
MX2020006587A
(es)
|
2017-12-22 |
2020-12-10 |
Ravenna Pharmaceuticals Inc |
Derivados de aminopiridina como inhibidores de fosfatidilinositol fosfato cinasa.
|
|
JP7399870B2
(ja)
|
2018-03-27 |
2023-12-18 |
ピーティーシー セラピューティクス， インコーポレイテッド |
ハンチントン病を処置するための化合物
|
|
US11530207B2
(en)
|
2018-04-10 |
2022-12-20 |
Skyhawk Therapeutics, Inc. |
Compounds for the treatment of cancer
|
|
JP2021523227A
(ja)
|
2018-05-04 |
2021-09-02 |
ストーク セラピューティクス，インク． |
コレステリルエステル蓄積症の処置のための方法及び組成物
|
|
KR20210038845A
(ko)
|
2018-06-27 |
2021-04-08 |
피티씨 테라퓨틱스, 인크. |
헌팅턴병 치료를 위한 헤테로아릴 화합물
|
|
PL3814357T3
(pl)
|
2018-06-27 |
2024-09-16 |
Ptc Therapeutics, Inc. |
Związki heterocykliczne i heteroarylowe do leczenia choroby huntingtona
|
|
JP2022519637A
(ja)
*
|
2019-02-04 |
2022-03-24 |
スカイホーク・セラピューティクス・インコーポレーテッド |
スプライシングを調節するための方法および組成物
|
|
EP3920910A4
(en)
*
|
2019-02-04 |
2022-11-09 |
Skyhawk Therapeutics, Inc. |
METHODS AND COMPOSITIONS FOR MODULATION OF SPLICING
|
|
KR20210135239A
(ko)
*
|
2019-02-05 |
2021-11-12 |
스카이호크 테라퓨틱스, 인코포레이티드 |
스플라이싱을 조절하는 방법 및 조성물
|
|
EP3920926A4
(en)
|
2019-02-05 |
2022-10-19 |
Skyhawk Therapeutics, Inc. |
Methods and compositions for modulating splicing
|
|
EP3920919A4
(en)
*
|
2019-02-05 |
2023-03-29 |
Skyhawk Therapeutics, Inc. |
METHODS AND COMPOSITIONS FOR MODULATING SPLICE
|
|
JP7603592B2
(ja)
*
|
2019-02-05 |
2024-12-20 |
スカイホーク・セラピューティクス・インコーポレーテッド |
スプライシングを調節するための方法および組成物
|
|
CN119638696A
(zh)
*
|
2019-02-06 |
2025-03-18 |
斯基霍克疗法公司 |
用于调节剪接的方法和组合物
|
|
WO2020163544A1
(en)
|
2019-02-06 |
2020-08-13 |
Skyhawk Therapeutics, Inc. |
Methods and compositions for modulating splicing
|
|
CN113748209A
(zh)
|
2019-02-27 |
2021-12-03 |
斯托克制药公司 |
用于治疗病况和疾病的反义寡聚体
|
|
CN114245794B
(zh)
|
2019-05-13 |
2024-09-13 |
Ptc医疗公司 |
用于治疗亨廷顿氏病的化合物
|
|
UY38687A
(es)
|
2019-05-17 |
2023-05-15 |
Novartis Ag |
Inhibidores del inflamasoma nlrp3, composiciones, combinaciones de los mismos y métodos para su uso
|
|
US11129829B2
(en)
|
2019-06-17 |
2021-09-28 |
Skyhawk Therapeutics, Inc. |
Methods for modulating splicing
|
|
TW202112767A
(zh)
|
2019-06-17 |
2021-04-01 |
美商佩特拉製藥公司 |
作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
|
|
CA3169667A1
(en)
*
|
2020-02-28 |
2021-09-02 |
Dominic Reynolds |
Pyridazine derivatives for modulating nucleic acid splicing
|
|
EP4110775A1
(en)
|
2020-02-28 |
2023-01-04 |
Remix Therapeutics Inc. |
Thiophenyl derivatives useful for modulating nucleic acid splicing
|
|
IL295955A
(en)
|
2020-02-28 |
2022-10-01 |
Remix Therapeutics Inc |
Compounds and methods for modulating splicing
|
|
JP2023515620A
(ja)
|
2020-02-28 |
2023-04-13 |
リミックス セラピューティクス インコーポレイテッド |
スプライシングを調節するための化合物及び方法
|
|
WO2021207554A1
(en)
|
2020-04-08 |
2021-10-14 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
WO2021207530A1
(en)
|
2020-04-08 |
2021-10-14 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
AU2021270720A1
(en)
|
2020-05-11 |
2022-12-08 |
Stoke Therapeutics, Inc. |
OPA1 antisense oligomers for treatment of conditions and diseases
|
|
EP4178963A1
(en)
|
2020-07-02 |
2023-05-17 |
Remix Therapeutics Inc. |
5-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases
|
|
KR20230051168A
(ko)
|
2020-07-02 |
2023-04-17 |
레믹스 테라퓨틱스 인크. |
2-(인다졸-5-일)-6-(피페리딘-4-일)-1,7-나프티리딘 유도체, 및 핵산 스플라이싱의 조절제로서의 및 증식성 질환의 치료를 위한 관련 화합물
|
|
CN112716946B
(zh)
*
|
2021-01-22 |
2022-02-08 |
中国人民解放军陆军军医大学 |
磺内酰胺-环己酮螺环衍生物1-3-51在制备治疗胃癌药物中的应用
|
|
IL311135A
(en)
|
2021-08-30 |
2024-04-01 |
Remix Therapeutics Inc |
Compounds and methods for modulating splicing
|
|
EP4395891A1
(en)
|
2021-08-30 |
2024-07-10 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
US20240368163A1
(en)
|
2021-08-30 |
2024-11-07 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
WO2023034836A1
(en)
|
2021-08-30 |
2023-03-09 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
WO2023034833A1
(en)
|
2021-08-30 |
2023-03-09 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
WO2023064880A1
(en)
|
2021-10-13 |
2023-04-20 |
Remix Therapeutics Inc. |
Compounds and methods for modulating nucleic acid splicing
|
|
WO2023064879A1
(en)
|
2021-10-13 |
2023-04-20 |
Remix Therapeutics Inc. |
Compounds and methods for modulating nucleic acid splicing
|
|
WO2023133225A1
(en)
|
2022-01-05 |
2023-07-13 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
US20250092065A1
(en)
|
2022-01-05 |
2025-03-20 |
Remix Therapeutics Inc. |
2-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases
|
|
US20250109140A1
(en)
|
2022-01-05 |
2025-04-03 |
Remix Theraputics Inc. |
5-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases
|
|
UY40374A
(es)
|
2022-08-03 |
2024-02-15 |
Novartis Ag |
Inhibidores de inflamasoma nlrp3
|
|
WO2025247338A1
(zh)
*
|
2024-05-30 |
2025-12-04 |
纽欧申医药(上海)有限公司 |
哒嗪环类化合物、其药物组合物及其应用
|